Skip to main content
. 2017 Sep 3;23(10):790–797. doi: 10.1111/cns.12724

Figure 2.

Figure 2

Analysis of TERT mutation in newly diagnosed and recurrent gliomas and different age groups. (A) Frequency of TERT promoter mutation in newly diagnosed and recurrent gliomas; Kaplan‐Meier curves show the survival of patients with C228T and C250T mutation and wild‐type TERT of the whole cohort. (B) Frequency and prognostic impact of TERT mutation in each age group (~19 years, 20‐39 years, 40‐59 years, ≥60 years). pMu: patients with TERT mutation; pWt: patients with wild‐type TERT